(R)-3-AMINO-3-(2,4-DICHLORO-PHENYL)-PROPIONIC ACID HCL, 96.0%, 250mg

[(S,S)-Teth-TsDpen RuCl], 98%, 5g

N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 98%, 10mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-cyanophenyl)propanoic acid, 98%, 5g

Ethyl 4,4-difluorocyclohexanecarboxylate, 97.0%, 500g

3,3,5,5-Tetramethyl-1-pyrroline N-Oxide>98.0%(GC)1g

Acenaphthenequinone>98.0%(GC)100g

Antimon Pulver, min. 99,5 %, ca. 325 mesh, 100 g, kunststoffverpackung.

C-(1-Methyl-1 H -benzoimidazol-2-yl)-methylamine, 95.0%, 10g

(S)-Benzyl 3-hydroxypiperidine-1-carboxylate, 95.0%, 250g

6-Methyl-4-phenyl-2-chromanone>98.0%(GC)25g

4-tert-Butylcyclohexylamine (cis- and trans- mixture)>98.0%(T)5mL

8-Bromo-4-chloro-2-methylquinoline, 95.0%, 1g